Cargando…
Duration of SARS-CoV-2 antigen positivity in hemodialysis patients
Autores principales: | Matsumoto, Jun, Saka, Yosuke, Mimura, Tetsushi, Naruse, Tomohiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812731/ https://www.ncbi.nlm.nih.gov/pubmed/35094656 http://dx.doi.org/10.1080/0886022X.2021.2013887 |
Ejemplares similares
-
Two cases of ceftriaxone‐induced encephalopathy treated by hemoperfusion in hemodialysis patients
por: Onogi, Chikao, et al.
Publicado: (2022) -
Duration of SARS-CoV-2 viral culture positivity among different specimen types
por: Kojima, Noah, et al.
Publicado: (2021) -
Duration for carrying SARS-CoV-2 in COVID-19 patients
por: Du, Xinwei, et al.
Publicado: (2020) -
Successful rituximab treatment of TAFRO syndrome with pathological findings of glomerular endothelial damage
por: Noda, Yuhei, et al.
Publicado: (2018) -
SARS-CoV-2–reactive cellular and humoral immunity in hemodialysis population
por: Anft, Moritz, et al.
Publicado: (2021)